1. "Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer;Engelsman;Eur J Cancer,1991
2. Initial findings of CALGB 8541: a dose and dose intensity trial of cyclophosphamide (C), doxorubicin (A), and 5-fluorouracil (F) as adjuvant treatment of stage II, node+, female breast cancer;Budman;Proc ASCO,1992
3. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes;Ludwig Breast Cancer Study Group;Cancer Res,1985
4. Late effects of adjuvant oophorectomy and chemotherapy upon pre-menopausal breast cancer patients;The International Breast Cancer Study Group;Ann Oncol,1990
5. Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast;Meakin;Can Med Assoc J,1979